Dose-escalation study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for stage III non-small cell lung cancer.

Authors

Naruo Yoshimura

Naruo Yoshimura

Department of Clinical Oncology, Graduate School of Medicine, Osaka City University, Osaka, Japan

Naruo Yoshimura , Shigeki Mitsuoka , Tatsuo Kimura , Hidenori Tanaka , Tomohiro Suzumura , Misato Nagata , Kanako Umekawa , Toshiyuki Nakai , Masako Hosono Hosono , Takuhito Tada , Kazuto Hirata , Shinzoh Kudoh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer - Non-small Cell Local-regional/Small Cell/Other Thoracic Cancers

Track

Lung Cancer

Sub Track

Local-Regional Non–Small Cell Lung Cancer

Clinical Trial Registration Number

UMIN000003769

Citation

J Clin Oncol 31, 2013 (suppl; abstr 7564)

DOI

10.1200/jco.2013.31.15_suppl.7564

Abstract #

7564

Poster Bd #

23B

Abstract Disclosures